Jupiter Neurosciences (JUNS) vs China SXT Pharmaceuticals (SXTC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Jupiter Neurosciences is the larger company by market cap ($3.7 million vs $428,535), about 8.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | JUNS | SXTC |
|---|---|---|
| Share price | $2.78 | $0.3243 |
| Market cap | $3.66M | $428.54K |
| 1-day change | -2.29% | -88.54% |
| Forward P/E | 46.25 | — |
| EPS (TTM) | $-18.94 | $-730.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $135.75 | $83,760.00 |
| 52-week low | $2.25 | $0.31 |
| Distance from 52-week high | -97.96% | -100.00% |
| Average volume | 982.67K | 3.73M |
| Shares outstanding | 1.32M | 1.32M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Jupiter Neurosciences is about 8.5 times larger than China SXT Pharmaceuticals by market value ($3.66M vs $428.54K).
JUNS vs SXTC FAQ
Which is bigger, Jupiter Neurosciences or China SXT Pharmaceuticals?
Jupiter Neurosciences (JUNS) is larger, with a market capitalization of $3.66M compared with $428.54K for China SXT Pharmaceuticals (SXTC).
Are Jupiter Neurosciences and China SXT Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.